<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="729">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05151666</url>
  </required_header>
  <id_info>
    <org_study_id>21-00989</org_study_id>
    <nct_id>NCT05151666</nct_id>
  </id_info>
  <brief_title>Exercise in Dialysis</brief_title>
  <official_title>Assessing the Impact of Intra-dialytic Exercise Regimen on Depression Scores</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the proposed clinical trial is to support intradialytic pedal cycling exercise&#xD;
      as an intervention and show its effect on depression and how there is a need for more&#xD;
      programs to support this. This is an exploratory single arm study. These patients will be&#xD;
      cycling during dialysis treatment by using a graded duration model. Even though patients on&#xD;
      hemodialysis (HD) have an increased life span due to renal replacement therapy, exercise can&#xD;
      have a remarkable effect on their ability to perform daily activities. Dialysis has been&#xD;
      shown to reduce self-confidence, increase social isolation, and cause feelings of&#xD;
      disappointment in the future. This population faces mental and psychological stress due to&#xD;
      the disease burden. Short-term supervised cycling programs while patients are receiving&#xD;
      dialysis have been reported to induce systematic improvements for depression and anxiety.&#xD;
      Exercise during hemodialysis is an effective way to reduce depressive symptoms without using&#xD;
      pharmacologic measures.&#xD;
&#xD;
      Data for each patient will be collected at each dialysis treatment using a unique patient&#xD;
      identifier. The data that will be collected include duration of exercise (intermittent or&#xD;
      continuous), any complications during HD, vital signs while cycling every 30 minutes, and how&#xD;
      they state they feel after cycling. The measurable outcome will be depression scores. The&#xD;
      tool that will be used for this project is the Beck Depression Inventory (BDI). The patient&#xD;
      will complete the BDI assessment on week 1 (pre intervention as baseline) and then on week 10&#xD;
      (post intervention).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 3, 2022</start_date>
  <completion_date type="Anticipated">March 5, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 5, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single arm pre-post intervention study design</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Beck Depression Inventory (BDI) Score</measure>
    <time_frame>Week 1, Week 10</time_frame>
    <description>BDI is a 21-item self-report scale designed to measure the severity of depressive symptoms. Each item is scored 0-3. The total score range is 0-63; the higher the score, the more severe the depression. A score &gt; 40 indicates extreme depression.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Hemodialysis Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sunny Health &amp; Fitness Magnetic Mini Exercise Pedal Cycle - SF-B020026 Gray</intervention_name>
    <description>The intervention will be that the patient cycles in a sitting position within the first 2 hours of hemodialysis treatment for 15-60 minutes/as tolerated, either intermittent/continuous duration. - Graded duration will increase every 2 weeks. This will be supervised by a dialysis nurse as per the schedule of study assessments.</description>
    <arm_group_label>Hemodialysis Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. greater than 18 years of age&#xD;
&#xD;
          2. male or female&#xD;
&#xD;
          3. ESKD on maintenance hemodialysis for 3 consecutive months&#xD;
&#xD;
          4. adequate dialysis clearances (Kt/V greater than 1.2),&#xD;
&#xD;
          5. able to participate in exercise program based on nephrologist evaluation&#xD;
&#xD;
          6. able to provide written informed consent for participation,&#xD;
&#xD;
          7. Compliance with dialysis treatment regimen (attended 75% of ordered dialysis&#xD;
             treatments in the last 3 months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. less than 18 years old&#xD;
&#xD;
          2. on hemodialysis for &lt; 3 consecutive months&#xD;
&#xD;
          3. acute Kidney Injury diagnosis&#xD;
&#xD;
          4. patients deemed clinically unstable by Nephrologist&#xD;
&#xD;
          5. active foot ulcer&#xD;
&#xD;
          6. unable to provide written consent&#xD;
&#xD;
          7. refusal of participation&#xD;
&#xD;
          8. lower limb amputations&#xD;
&#xD;
          9. patients with dementia or severe cognitive impairment&#xD;
&#xD;
         10. patients with Psychiatric disorders (who are not treated and unstable)&#xD;
&#xD;
         11. pregnancy&#xD;
&#xD;
         12. myocardial infarction in the last 6 months&#xD;
&#xD;
         13. uncontrolled diabetes&#xD;
&#xD;
         14. patients on chronic Midodrine therapy for intradialytic blood pressure support.&#xD;
&#xD;
         15. deep vein thrombosis&#xD;
&#xD;
         16. symptomatic peripheral vascular disease and/or recent lower extremities vascular&#xD;
             intervention (i.e. bypass)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naveed Masani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Naveed Masani, MD</last_name>
    <phone>516-663-2169</phone>
    <email>Naveed.Masani@nyulangone.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Faith Lynch, MSN, RN, CNN</last_name>
    <phone>516-663-3498</phone>
    <email>Faith.Lynch@nyulangone.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NYU Dialysis Center of Bethpage</name>
      <address>
        <city>Bethpage</city>
        <state>New York</state>
        <zip>11714</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Naveed Masani, MD</last_name>
      <email>Naveed.Masani@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>Faith Lynch, MSN, RN, CNN</last_name>
      <email>Faith.Lynch@nyulangone.org</email>
    </contact_backup>
    <investigator>
      <last_name>Naveed Masani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Faith Lynch, MSN, RN, CNN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula Dutka, MSN, RN, CNN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Winthrop Dialysis Center - Outpatient</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Naveed Masani, MD</last_name>
      <email>Naveed.Masani@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>Faith Lynch, MSN, RN, CNN</last_name>
      <email>Faith.Lynch@nyulangone.org</email>
    </contact_backup>
    <investigator>
      <last_name>Naveed Masani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Faith Lynch, MSN, RN, CNN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula Dutka, MSN, RN, CNN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 1, 2021</study_first_submitted>
  <study_first_submitted_qc>December 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared upon reasonable request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.</ipd_time_frame>
    <ipd_access_criteria>The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to Naveed.Masani@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

